BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36258717)

  • 1. Silibinin Radiosensitizes EGF Receptor-knockdown Prostate Cancer Cells by Attenuating DNA Repair Pathways.
    Rajput M; Mishra D; Kumar K; Singh RP
    J Cancer Prev; 2022 Sep; 27(3):170-181. PubMed ID: 36258717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
    Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
    Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
    Tyagi A; Sharma Y; Agarwal C; Agarwal R
    Pharm Res; 2008 Sep; 25(9):2143-50. PubMed ID: 18253818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways.
    Rajput M; Singh R; Singh N; Singh RP
    Life Sci; 2021 Dec; 286():120031. PubMed ID: 34627777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells.
    Sharma Y; Agarwal C; Singh AK; Agarwal R
    Mol Carcinog; 2001 Apr; 30(4):224-36. PubMed ID: 11346885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells.
    Golding SE; Morgan RN; Adams BR; Hawkins AJ; Povirk LF; Valerie K
    Cancer Biol Ther; 2009 Apr; 8(8):730-8. PubMed ID: 19252415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells.
    Nambiar DK; Rajamani P; Singh RP
    Biochem Biophys Res Commun; 2015 Jan; 456(1):262-8. PubMed ID: 25446081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-homologous end-joining pathway is not involved in the radiosensitization of mammalian cells by heat shock.
    Dynlacht JR; Bittner ME; Bethel JA; Beck BD
    J Cell Physiol; 2003 Sep; 196(3):557-64. PubMed ID: 12891712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells.
    Agarwal C; Tyagi A; Kaur M; Agarwal R
    Carcinogenesis; 2007 Jul; 28(7):1463-70. PubMed ID: 17341659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
    Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer preventive flavonoid silibinin causes hypophosphorylation of Rb/p107 and Rb2/p130 via modulation of cell cycle regulators in human prostate carcinoma DU145 cells.
    Tyagi A; Agarwal C; Agarwal R
    Cell Cycle; 2002; 1(2):137-42. PubMed ID: 12429923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways.
    Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
    Cell Death Dis; 2014 Oct; 5(10):e1437. PubMed ID: 25275598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells.
    Kavitha CV; Deep G; Gangar SC; Jain AK; Agarwal C; Agarwal R
    Mol Carcinog; 2014 Mar; 53(3):169-80. PubMed ID: 23115104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
    Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM
    Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line.
    Qi L; Singh RP; Lu Y; Agarwal R; Harrison GS; Franzusoff A; Glode LM
    Cancer Biol Ther; 2003; 2(5):526-31. PubMed ID: 14614320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways.
    Estrada-Bernal A; Chatterjee M; Haque SJ; Yang L; Morgan MA; Kotian S; Morrell D; Chakravarti A; Williams TM
    Cell Cycle; 2015; 14(23):3713-24. PubMed ID: 26505547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.